| Product Code: ETC4632520 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Overview |
3.1 Antigua and Barbuda Country Macro Economic Indicators |
3.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Antigua and Barbuda Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.6 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.7 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Antigua and Barbuda |
4.2.2 Growing awareness about the importance of early disease detection and treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to point-of-care testing |
4.3 Market Restraints |
4.3.1 Limited healthcare budget leading to affordability issues for point-of-care testing |
4.3.2 Lack of skilled healthcare professionals to administer and interpret test results effectively |
4.3.3 Regulatory challenges and approvals delaying the introduction of new point-of-care testing technologies |
5 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Trends |
6 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Segmentations |
6.1 Antigua and Barbuda Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2021-2031F |
6.1.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2021-2031F |
6.1.4 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2021-2031F |
6.1.5 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2021-2031F |
6.1.6 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
6.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2021-2031F |
6.2.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2021-2031F |
6.2.4 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2021-2031F |
6.2.5 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2021-2031F |
6.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021-2031F |
6.3.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.4 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2021-2031F |
6.3.5 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of infectious disease cases diagnosed through point-of-care testing |
8.2 Adoption rate of point-of-care testing in healthcare facilities across Antigua and Barbuda |
8.3 Average turnaround time for test results to be delivered to patients |
9 Antigua and Barbuda Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.3 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Antigua and Barbuda Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2024 |
10.2 Antigua and Barbuda Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here